Description

Adipotide Nasal Spray

Adipotide
CAS Number	137525-51-0
Molar Mass	2555.22 g/mol-1
Chemical Formula	C111H204N36O28S2
IUPAC Name	hexanediamide

Introduction

Adipotide is a research product designed exclusively for scientific purposes. It is essential to emphasize that Adipotide Nasal Spray is not intended for human consumption but is developed for research applications only. This compound has garnered attention in scientific circles for its potential implications in various areas of study.

Key Characteristics

Adipotide is a peptide mimetic compound known for its specificity in targeting adipose tissue. Its unique properties make it a valuable tool in research dedicated to understanding metabolic processes and related conditions.

Research Applications

Adipotide Nasal Spray finds applications in diverse research domains, including metabolic studies, obesity-related investigations, and explorations into insulin resistance and glucose tolerance.

Research Benefits

Adipotide and Fat Loss

Studies suggest a potential link between Adipotide and fat loss. Research indicates that Adipotide may influence adipose tissue, leading to a reduction in fat mass.

Adipotide and Insulin Resistance

Preliminary findings propose that Adipotide may play a role in addressing insulin resistance. Research in animal models suggests that Adipotide could positively impact insulin sensitivity

Adipotide and Glucose Tolerance

Exploratory studies indicate potential implications of Adipotide in glucose tolerance. Investigations suggest that Adipotide may contribute to improved glucose regulation.

Summary

Adipotide Nasal Spray offers a specialized tool for researchers investigating various aspects of metabolism, obesity, insulin resistance, and glucose tolerance. It is crucial to underline that the use of Adipotide is strictly limited to research purposes, and its application in any other context, including human consumption, is strictly prohibited.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Kirstin F. Barnhart et al., Response to Comment on “A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys”.Sci. Transl. Med.4,131lr2-131lr2(2012).DOI:10.1126/scitranslmed.3004103 [Read More]
2. Rosa-Gonçalves, P., Majerowicz, D. Pharmacotherapy of Obesity: Limits and Perspectives. Am J Cardiovasc Drugs 19, 349–364 (2019). [Read More]